These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8986728)

  • 21. Longitudinal study to assess the safety and efficacy of a live-attenuated SHIV vaccine in long term immunized rhesus macaques.
    Yankee TM; Sheffer D; Liu Z; Dhillon S; Jia F; Chebloune Y; Stephens EB; Narayan O
    Virology; 2009 Jan; 383(1):103-11. PubMed ID: 18986665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Annual updated survey of worldwide HIV, SIV, and SHIV challenge studies in vaccinated nonhuman primates.
    Warren JT; Dolatshahi M
    J Med Primatol; 1994; 23(2-3):184-225. PubMed ID: 7966234
    [No Abstract]   [Full Text] [Related]  

  • 23. Attenuated retrovirus vaccines and AIDS.
    Van Rompay KK; Spinner A; Otsyula M; McChesney MB; Marthas ML
    Science; 1995 Nov; 270(5239):1218-9; author reply 1220-2. PubMed ID: 7502051
    [No Abstract]   [Full Text] [Related]  

  • 24. Chimeric adenovirus type 5/35 vector encoding SIV gag and HIV env genes affords protective immunity against the simian/human immunodeficiency virus in monkeys.
    Someya K; Xin KQ; Ami Y; Izumi Y; Mizuguchi H; Ohta S; Yamamoto N; Honda M; Okuda K
    Virology; 2007 Oct; 367(2):390-7. PubMed ID: 17628628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
    Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
    Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune correlates of protection from HIV and AIDS - more answers but yet more questions.
    Heeney JL; Beverley P; McMichael A; Shearer G; Strominger J; Wahren B; Weber J; Gotch F
    Immunol Today; 1999 Jun; 20(6):247-51. PubMed ID: 10354547
    [No Abstract]   [Full Text] [Related]  

  • 27. Protection against late-onset AIDS in macaques prophylactically immunized with a live simian HIV vaccine was dependent on persistence of the vaccine virus.
    Mackay GA; Liu Z; Singh DK; Smith MS; Mukherjee S; Sheffer D; Jia F; Adany I; Sun KH; Dhillon S; Zhuge W; Narayan O
    J Immunol; 2004 Sep; 173(6):4100-7. PubMed ID: 15356160
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Live attenuated viruses: a new strategy for vaccination against AIDS].
    Molina JM
    Pathol Biol (Paris); 1993 Jun; 41(6):513-4. PubMed ID: 8247628
    [No Abstract]   [Full Text] [Related]  

  • 29. Protective effects of nef-deleted SHIV or that having IFN-gamma against disease induced with a pathogenic virus early after vaccination.
    Enose Y; Kita M; Yamamoto T; Suzuki H; Miyake A; Horiuchi R; Ibuki K; Kaneyasu K; Kuwata T; Takahashi E; Sakai K; Shinohara K; Miura T; Hayami M
    Arch Virol; 2004 Sep; 149(9):1705-20. PubMed ID: 15593414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Why do we not have an HIV vaccine and how can we make one?
    Burton DR; Moore JP
    Nat Med; 1998 May; 4(5 Suppl):495-8. PubMed ID: 9585194
    [No Abstract]   [Full Text] [Related]  

  • 31. 25 years of HIV research! ... and what about a vaccine?
    Appay V
    Eur J Immunol; 2009 Aug; 39(8):1999-2003. PubMed ID: 19672891
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dominant induction of vaccine antigen-specific cytotoxic T lymphocyte responses after simian immunodeficiency virus challenge.
    Takahara Y; Matsuoka S; Kuwano T; Tsukamoto T; Yamamoto H; Ishii H; Nakasone T; Takeda A; Inoue M; Iida A; Hara H; Shu T; Hasegawa M; Sakawaki H; Horiike M; Miura T; Igarashi T; Naruse TK; Kimura A; Matano T
    Biochem Biophys Res Commun; 2011 May; 408(4):615-9. PubMed ID: 21531211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuated vaccines for AIDS.
    Victorino RM; Sousa AE
    Lancet; 1995 Jul; 346(8968):179. PubMed ID: 7603240
    [No Abstract]   [Full Text] [Related]  

  • 34. Development of an AIDS vaccine: a daunting epidemiological challenge.
    Nathanson N; Mathieson BJ
    Eur J Epidemiol; 2005; 20(2):123-6. PubMed ID: 15792276
    [No Abstract]   [Full Text] [Related]  

  • 35. Attenuated retrovirus vaccines and AIDS.
    Shearer GM; Lucey DR; Clerici M
    Science; 1995 Nov; 270(5239):1219; author reply 1220-2. PubMed ID: 7502053
    [No Abstract]   [Full Text] [Related]  

  • 36. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes.
    Barouch DH; Kunstman J; Kuroda MJ; Schmitz JE; Santra S; Peyerl FW; Krivulka GR; Beaudry K; Lifton MA; Gorgone DA; Montefiori DC; Lewis MG; Wolinsky SM; Letvin NL
    Nature; 2002 Jan; 415(6869):335-9. PubMed ID: 11797012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monkey Models and HIV Vaccine Research.
    Chen Z
    Adv Exp Med Biol; 2018; 1075():97-124. PubMed ID: 30030791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. "Attenuated" simian immunodeficiency virus in macaque neonates.
    Ruprecht RM; Baba TW; Liska V; Bronson R; Penninck D; Greene MF
    AIDS Res Hum Retroviruses; 1996 Mar; 12(5):459-60. PubMed ID: 8882333
    [No Abstract]   [Full Text] [Related]  

  • 39. A novel chimeric Rev, Tat, and Nef (Retanef) antigen as a component of an SIV/HIV vaccine.
    Hel Z; Johnson JM; Tryniszewska E; Tsai WP; Harrod R; Fullen J; Tartaglia J; Franchini G
    Vaccine; 2002 Aug; 20(25-26):3171-86. PubMed ID: 12163269
    [TBL] [Abstract][Full Text] [Related]  

  • 40. AIDS vaccines: is older better?
    Cohen J
    Science; 1992 Dec; 258(5090):1880-1. PubMed ID: 1470911
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.